← Back to headlines
Eli Lilly Expands Pipeline with Clazakizumab Agreement
Eli Lilly (LLY) is reportedly expanding its pharmaceutical pipeline through a new agreement involving Clazakizumab, as reported by Reuters.
20 Feb, 23:34 — 20 Feb, 23:34
Sources
Showing 1 of 1 sources
Related Stories
South Korean Retail Investors Shift Billions to US Stocks Amid ETF Curbs
24m ago
HDFC Bank CEO Sashidhar Jagdishan to Step Down in October
3h ago
FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder
4h ago
UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings
4h ago